191 related articles for article (PubMed ID: 8836413)
1. The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G
Ann Oncol; 1996; 7 Suppl 4():67-72. PubMed ID: 8836413
[TBL] [Abstract][Full Text] [Related]
2. Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group.
Schellong G
Baillieres Clin Haematol; 1996 Sep; 9(3):619-34. PubMed ID: 8922249
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group.
Schellong G; Brämswig JH; Hörnig-Franz I; Schwarze EW; Pötter R; Wannenmacher M
Ann Oncol; 1994; 5 Suppl 2():113-5. PubMed ID: 8204510
[TBL] [Abstract][Full Text] [Related]
4. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
[TBL] [Abstract][Full Text] [Related]
5. Treatment of children with Hodgkin's disease--results of the German Pediatric Oncology Group.
Schellong G; Brämswig JH; Hörnig-Franz I
Ann Oncol; 1992 Sep; 3 Suppl 4():73-6. PubMed ID: 1450084
[TBL] [Abstract][Full Text] [Related]
6. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
Mauz-Körholz C; Landman-Parker J; Balwierz W; Ammann RA; Anderson RA; Attarbaschi A; Bartelt JM; Beishuizen A; Boudjemaa S; Cepelova M; Claviez A; Daw S; Dieckmann K; Fernández-Teijeiro A; Fosså A; Gattenlöhner S; Georgi T; Hjalgrim LL; Hraskova A; Karlén J; Kluge R; Kurch L; Leblanc T; Mann G; Montravers F; Pears J; Pelz T; Rajić V; Ramsay AD; Stoevesandt D; Uyttebroeck A; Vordermark D; Körholz D; Hasenclever D; Wallace WH
Lancet Oncol; 2022 Jan; 23(1):125-137. PubMed ID: 34895479
[TBL] [Abstract][Full Text] [Related]
7. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
8. [Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82].
Schellong G; Brämswig J; Ludwig R; Gerein V; Jobke A; Jürgens H; Kabisch H; Stollmann B; Weinel P; Gadner H
Klin Padiatr; 1986; 198(3):137-46. PubMed ID: 3523020
[TBL] [Abstract][Full Text] [Related]
9. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies.
Schellong G; Brämswig JH; Schwarze EW; Wannenmacher M
Bull Cancer; 1988; 75(1):41-51. PubMed ID: 3282575
[TBL] [Abstract][Full Text] [Related]
10. [Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85].
Schellong G; Hörnig I; Brämswig J; Bökkerink JP; Steinhoff A; Ludwig R; Niethammer D; Reiter A; von Lengerke HJ; Heinecke H
Klin Padiatr; 1988; 200(3):205-13. PubMed ID: 3062257
[TBL] [Abstract][Full Text] [Related]
11. [Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD-87 therapy study].
Schellong G; Hörnig-Franz I; Rath B; Ritter J; Riepenhausen M; Kabisch H; Goldschmitt-Wuttge B; Schmidt P; Niethammer D; Gaedicke G
Klin Padiatr; 1994; 206(4):253-62. PubMed ID: 7967421
[TBL] [Abstract][Full Text] [Related]
12. Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua.
Baez F; Ocampo E; Conter V; Flores A; Gutierrez T; Malta A; Pacheco C; Palacios R; Biondi A; Riva L; Sala A; Silvestri D; Cavalli F; Sessa C; Casanova M; Masera G
Ann Oncol; 1997 Mar; 8(3):247-50. PubMed ID: 9137793
[TBL] [Abstract][Full Text] [Related]
13. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.
Brämswig JH; Heimes U; Heiermann E; Schlegel W; Nieschlag E; Schellong G
Cancer; 1990 Mar; 65(6):1298-302. PubMed ID: 2106384
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Loeffler M; Diehl V; Pfreundschuh M; Rühl U; Hasenclever D; Nisters-Backes H; Sieber M; Tesch H; Franklin J; Geilen W; Bartels H; Cartoni C; Dölken G; Enzian J; Fuchs R; Gassmann W; Gerhartz H; Hagen-Aukamp U; Hiller E; Hinkelbein H; Hinterberger W; Kirchner H; Koch P; Krüger B; Schwarze EW
J Clin Oncol; 1997 Jun; 15(6):2275-87. PubMed ID: 9196141
[TBL] [Abstract][Full Text] [Related]
15. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
[TBL] [Abstract][Full Text] [Related]
16. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Oberlin O; Leverger G; Pacquement H; Raquin MA; Chompret A; Habrand JL; Terrier-Lacombe MJ; Bey P; Bertrand Y; Rubie H
J Clin Oncol; 1992 Oct; 10(10):1602-8. PubMed ID: 1383434
[TBL] [Abstract][Full Text] [Related]
17. ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group.
Cullen MH; Stuart NS; Woodroffe C; Murphy A; Fletcher J; Blackledge GR; Child JA; Grieve RJ; Jones EL
J Clin Oncol; 1994 Apr; 12(4):779-87. PubMed ID: 7512132
[TBL] [Abstract][Full Text] [Related]
18. [Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Diehl V; Pfreundschuh M; Löffler M; Smith K; Rühl U; Georgii A; Hiller E; Gerhartz H
Onkologie; 1987 Apr; 10(2):62-6. PubMed ID: 2438613
[TBL] [Abstract][Full Text] [Related]
19. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience.
Ortin TT; Shostak CA; Donaldson SS
Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):873-80. PubMed ID: 2211255
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group].
Pfreundschuh M; Löffler M; Rühl U; Hiller E; Gerhartz H; Wilmanns W; Kirchner H; Schoppe W; Petsch S; Bartels H
Onkologie; 1988 Feb; 11(1):48-52. PubMed ID: 2452393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
